Close Menu

Not So Useful?

An study in the Journal of the American Medical Association found that there was no significant association between a genetic risk score — based on 101 SNPs — and incidence of cardiovascular disease in Caucasian women. Brigham and Women's Hospital's Nina Paynter and her colleagues followed 19,313 participants in the Women's Genome Health Study for a median of 12.3 years and determined the participants' genetic risk scores based on genome-wide association study results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.